(Washington, DC – August 4, 2014) –  The 2014 edition of US News and World Report’s annual “Best Hospitals” issue hit the stands today, featuring Galileo Analytics Co-Founder Anna McCollister-Slipp in an article about the future of digital health. 85

Written by veteran journalist Elizabeth Gardner, the article discusses McCollister-Slipp’s use of digital health and wellness tools to manage her type 1 diabetes and the promise of these digital technologies to transform healthcare, as well as her frustration with a lack of data access and medical device interoperability and how that unnecessarily inhibits the devices’ value for patients.

In addition to McCollister-Slipp, the article features noted digital health experts, such as Dr. Eric Topol of the Scripps Translational Science Institute, Dr. Danny Sands of the Beth Israel Deaconess Medical Center and Co-Founder of the Society for Participatory Medicine and Dr. Farzad Mostashari, former National Coordinator of the Office of Information Technology at the Department of Health and Human Services.

To read the full article visit www.health.usnews.com or click here: “Need a Diagnosis or Checkup? Your Smartphone Is On Call: Apps and handheld devices are revolutionizing care”.

Admin

About Admin

Anna McCollister-Slipp is co-founder of Galileo Analytics, a Visual Data Exploration and advanced data analytics company focused on democratizing access to and understanding of complex health data. In addition, she is the Chief Advocate for Participatory Research at the Scripps Translational Science Institute, where she is charged with bringing the expertise of patients, caregivers and community physicians into the design of health research. Anna’s passion for innovation in health data research is rooted in her personal experiences living with type 1 diabetes. As an entrepreneur and advocate, she speaks frequently about the promise of digital health, the imperative for patient data access and the need for improved outcomes measures for chronic disease. Anna serves on a number of government and private committees and boards aimed at promoting innovative ways to better understand, manage and treat complex health conditions, such as diabetes.

%d bloggers like this: